Safety and Efficacy Study of SUN-131 Transdermal System (TDS) as Compared to Placebo TDS in Patients With a Chalazion
Clinical trial NCT03248440 · COMPLETED
Trial details
- NCT number
- NCT03248440
- Sponsor
- Senju USA, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-07-31
- Primary completion
- 2018-08-17
- Enrollment
- 263
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.